FDA Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.
Related Articles
Dr Garmezy on the Rationale for Developing Zelenectide Pevedotin in Urothelial Cancer
Benjamin Garmezy, MD, discusses the rationale for developing zelenectide pevedotin in metastatic urothelial carcinoma.
The new NCCN guidelines for immunotherapy-related toxicities – OncoDaily
The new NCCN guidelines for immunotherapy-related toxicities / cancer, CAR T-cell therapy, Elvina Almuradova, European School of Oncology, fight against
Cilta-Cel Leads to 100% MRD-Negativity Rate in High-Risk Smoldering Multiple Myeloma
Cilta-cel without induction therapy in high-risk smoldering myeloma marked the first study of CAR T-cell therapy in a precursor cancer setting.
BCMA-directed CAR T-cell Therapy in patients with multiple myeloma and CNS involvement
Key Points. BCMA-directed CART in patients with multiple myeloma and CNS involvement is feasible without excess neurotoxicityData suggests consideration fo
UCSF Hematology Oncology Student Interest Group
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 500+ Peer Reviewed papers,…
Momelotinib Shows Real-World Improvements in Anemia, Symptoms, and Spleen Response in Myelofibrosis
Real-world treatment with momelotinib led to high transfusion independence rates among patients with JAK inhibitor–exposed and –naive myelofibrosis.
BCMA-directed CAR T-cell Therapy in patients with multiple myeloma and CNS involvement
Key Points. BCMA-directed CART in patients with multiple myeloma and CNS involvement is feasible without excess neurotoxicityData suggests consideration fo
Asciminib and Ponatinib Sit at the Forefront of Advances in CML Management: Insights From Onyee Chan, MD; and Bradley D. Hunter, MD
Drs Chan and Hunter discuss asciminib in first-line CML, OPTIC trial data on ponatinib dosing, mutational testing, and stem cell transplant strategies.
Algorithm could help prevent thousands of strokes in UK each year
Tool uses machine learning to analyse medical data for red flags relating to undiagnosed atrial fibrillation
